"اكبر مستشفي في مصر .. خدمة طبية علي اعلي مستوي دائما"

During the past decade, Alexandria University Hospital conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 4 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 1 clinical trials were completed. i.e. 6.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alexandria University Hospital" #1 sponsor was "Alexandria University" with 7 trials, followed by "University of Alexandria" with 3 trials sponsored, "Assiut University" with 2 trials sponsored, "Astellas Pharma Inc" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alexandria University Hospital" #1 collaborator was "Basilea Pharmaceutica International Ltd" with 2 trials as a collaborator, "Alexandria University" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "University of Cape Town" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Alexandria University Hospital" are "Amebiasis" (2 trials), "Aspergillosis" (2 trials), "Invasive Fungal Infections" (2 trials), "Sickle Cell Disease" (2 trials) and "Acute Kidney Injury" (1 trials). Many other conditions were trialed in "Alexandria University Hospital" in a lesser frequency.

Most popular intervention types in "Alexandria University Hospital" are "Drug" (16 trials), "Other" (7 trials), "Procedure" (4 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nitazoxanide" (2 trials), "Placebo" (2 trials), "Voxelotor" (2 trials), "Avastin" (1 trials) and "BI 695502" (1 trials). Other intervention names were less common.

The vast majority of trials in "Alexandria University Hospital" are 27 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Alexandria University Hospital". 2 are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Alexandria University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Alexandria University Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".